Trial Profile

An Open-label, Fixed-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Rifampin on Pharmacokinetics of NKTR-118 in Healthy Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Nov 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naloxegol (Primary) ; Rifampicin
Indications Constipation; Tuberculosis
Focus Pharmacokinetics
Sponsors AstraZeneca

Most Recent Events

17 Dec 2015 Results of this and other two trials (see profile 212872 and 217552) were published in the Journal of Clinical Pharmacology
11 Dec 2012 Actual end date changed from Jul 2012 to May 2012 as reported by ClinicalTrials.gov.
19 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com